KR20150017387A - 영상화를 위한 표지된 hgf 결합성 펩티드 - Google Patents

영상화를 위한 표지된 hgf 결합성 펩티드 Download PDF

Info

Publication number
KR20150017387A
KR20150017387A KR1020157002055A KR20157002055A KR20150017387A KR 20150017387 A KR20150017387 A KR 20150017387A KR 1020157002055 A KR1020157002055 A KR 1020157002055A KR 20157002055 A KR20157002055 A KR 20157002055A KR 20150017387 A KR20150017387 A KR 20150017387A
Authority
KR
South Korea
Prior art keywords
cys
peptide
group
gly
cmbp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157002055A
Other languages
English (en)
Korean (ko)
Inventor
에드빈 빌헬름 요한슨
알란 커스버트슨
Original Assignee
지이 헬스케어 에이에스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0709441A external-priority patent/GB0709441D0/en
Priority claimed from GB0715682A external-priority patent/GB0715682D0/en
Application filed by 지이 헬스케어 에이에스 filed Critical 지이 헬스케어 에이에스
Publication of KR20150017387A publication Critical patent/KR20150017387A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4842—Monitoring progression or stage of a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medical Informatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Solid State Image Pick-Up Elements (AREA)
KR1020157002055A 2007-05-16 2008-05-16 영상화를 위한 표지된 hgf 결합성 펩티드 Ceased KR20150017387A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0709441A GB0709441D0 (en) 2007-05-16 2007-05-16 Peptide imaging agents
GB0709441.0 2007-05-16
GB0715682.1 2007-08-13
GB0715682A GB0715682D0 (en) 2007-08-13 2007-08-13 Peptide imaging agents
PCT/GB2008/001696 WO2008139207A2 (en) 2007-05-16 2008-05-16 Labelled hgf binding peptides for imaging

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020097023746A Division KR101578225B1 (ko) 2007-05-16 2008-05-16 영상화를 위한 표지된 hgf 결합성 펩티드

Publications (1)

Publication Number Publication Date
KR20150017387A true KR20150017387A (ko) 2015-02-16

Family

ID=39743846

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020157002055A Ceased KR20150017387A (ko) 2007-05-16 2008-05-16 영상화를 위한 표지된 hgf 결합성 펩티드
KR1020097023746A Expired - Fee Related KR101578225B1 (ko) 2007-05-16 2008-05-16 영상화를 위한 표지된 hgf 결합성 펩티드

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020097023746A Expired - Fee Related KR101578225B1 (ko) 2007-05-16 2008-05-16 영상화를 위한 표지된 hgf 결합성 펩티드

Country Status (17)

Country Link
US (1) US8529874B2 (cg-RX-API-DMAC10.html)
EP (1) EP2146749B1 (cg-RX-API-DMAC10.html)
JP (1) JP2010526859A (cg-RX-API-DMAC10.html)
KR (2) KR20150017387A (cg-RX-API-DMAC10.html)
CN (1) CN101848734B (cg-RX-API-DMAC10.html)
AT (1) ATE551073T1 (cg-RX-API-DMAC10.html)
AU (1) AU2008249821B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0811210B1 (cg-RX-API-DMAC10.html)
CA (1) CA2685553C (cg-RX-API-DMAC10.html)
ES (1) ES2385066T3 (cg-RX-API-DMAC10.html)
IL (1) IL201778A0 (cg-RX-API-DMAC10.html)
MX (1) MX2009012386A (cg-RX-API-DMAC10.html)
NZ (1) NZ581160A (cg-RX-API-DMAC10.html)
PL (1) PL2146749T3 (cg-RX-API-DMAC10.html)
RU (2) RU2473361C9 (cg-RX-API-DMAC10.html)
WO (1) WO2008139207A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA200908016B (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2148702A2 (en) * 2007-05-16 2010-02-03 GE Healthcare AS Pentamethine cyanine dyes carrying at least three sulfonic acid groups
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0918321D0 (en) 2009-10-20 2009-12-02 Ge Healthcare As Cyclic peptide synthesis
EP2588541A1 (en) * 2010-06-29 2013-05-08 GE Healthcare AS Dye compositions and dye syntheses
GB201010878D0 (en) 2010-06-29 2010-08-11 Ge Healthcare As Dye compositiion and dye syntheses
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
US20120088262A1 (en) * 2010-10-06 2012-04-12 Millipore Corporation Cyanine compounds, conjugates and method of use
MX2013010012A (es) 2011-03-01 2014-04-14 Ge Healthcare Ltd Analogos de octreotato radiomarcado como trazadores de tomografia por emision de positrones.
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
DE102011118029A1 (de) * 2011-06-20 2012-12-20 Universität Leipzig Modifizierte antibiotische Peptide mit variabler systemischer Freisetzung
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
GB201116862D0 (en) 2011-09-30 2011-11-09 Ge Healthcare As Infusion imaging method
GB201121914D0 (en) * 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
US10046068B2 (en) * 2013-03-15 2018-08-14 Arizona Board Of Regents On Behalf Of Arizona State University Saccharide conjugates
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
CN105111773B (zh) * 2015-08-19 2017-06-27 大连理工大学 一类氨基菁类荧光染料及其制备方法和应用
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
CN112129736B (zh) * 2020-09-22 2022-08-02 四川大学华西医院 粘蛋白和循环肿瘤细胞的均相可视化/荧光poct检测方法
WO2022258455A1 (en) * 2021-06-07 2022-12-15 Surgvision Gmbh Stable liquid phantom for near-infrared fluorescence verification
TW202404643A (zh) 2022-04-20 2024-02-01 大陸商同宜醫藥(蘇州)有限公司 化合物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615646B2 (en) * 2002-05-10 2009-11-10 Carnegie Mellon University Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
GB0223249D0 (en) * 2002-10-08 2002-11-13 Amersham Plc Improved imaging agents
US7510699B2 (en) * 2003-02-19 2009-03-31 Sicel Technologies, Inc. In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes
ES2557286T3 (es) * 2003-03-03 2016-01-25 Dyax Corp. Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
EP1678258B1 (en) * 2003-10-31 2011-08-31 GE Healthcare Limited Cyanine dye labelling reagents
US7785566B2 (en) 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
NO20035682D0 (no) 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av ösofagkreft og Barretts ösofag
US8236283B2 (en) * 2005-01-06 2012-08-07 Ge Healthcare As Optical imaging
WO2006078914A1 (en) * 2005-01-21 2006-07-27 Washington University In St. Louis Compounds having rd targeting motifs
GB0502277D0 (en) 2005-02-04 2005-03-09 Amersham Plc Novel imaging agents
EP1877428B1 (en) * 2005-04-22 2011-03-16 University of Washington Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer
NO20053354D0 (no) 2005-07-11 2005-07-11 Amersham Health As Optical imaging contrast agent.

Also Published As

Publication number Publication date
IL201778A0 (en) 2010-06-16
RU2473361C9 (ru) 2013-06-20
CN101848734A (zh) 2010-09-29
PL2146749T3 (pl) 2012-09-28
RU2473361C2 (ru) 2013-01-27
CN101848734B (zh) 2013-08-28
BRPI0811210B1 (pt) 2021-11-09
US20100150843A1 (en) 2010-06-17
EP2146749B1 (en) 2012-03-28
RU2009140478A (ru) 2011-06-27
US8529874B2 (en) 2013-09-10
KR20100016543A (ko) 2010-02-12
MX2009012386A (es) 2009-12-03
RU2475266C2 (ru) 2013-02-20
NZ581160A (en) 2012-05-25
JP2010526859A (ja) 2010-08-05
ES2385066T3 (es) 2012-07-17
BRPI0811210A2 (pt) 2014-11-11
WO2008139207A3 (en) 2009-02-26
EP2146749A2 (en) 2010-01-27
AU2008249821A1 (en) 2008-11-20
CA2685553A1 (en) 2008-11-20
AU2008249821B2 (en) 2013-08-22
WO2008139207A2 (en) 2008-11-20
ZA200908016B (en) 2012-04-25
RU2009140475A (ru) 2011-06-27
ATE551073T1 (de) 2012-04-15
CA2685553C (en) 2017-03-28
KR101578225B1 (ko) 2015-12-17

Similar Documents

Publication Publication Date Title
KR101578225B1 (ko) 영상화를 위한 표지된 hgf 결합성 펩티드
US8431111B2 (en) Peptide imaging agents
RU2484111C9 (ru) Агенты для оптической визуализации
AU2019246196B2 (en) Formulation and method of preparation
US20110268660A1 (en) Method for detecting dysplasia
WO2013045662A1 (en) Peptide margin imaging agents
RU2802481C2 (ru) Состав для оптической визуализации, способ его получения и применение
HK1148476A (en) Labelled hgf binding peptides for imaging
WO2013045650A2 (en) Infusion imaging method
HK40047564A (en) Formulation and method of preparation

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150126

Application number text: 1020097023746

Filing date: 20091113

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20150225

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150513

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160217

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150513

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I